Ebbel Matthew 4
4 · AdaptHealth Corp. · Filed Mar 8, 2022
Insider Transaction Report
Form 4
SkyKnight Aero Holdings, LLC
Director
Transactions
- Conversion
Series C Preferred Stock
2021-03-19−27,324.4→ 0 total→ Class A Common Stock (2,732,440 underlying) - Conversion
Class A Common Stock
2021-03-19+1,171,045→ 2,426,919 total(indirect: By SkyKnight Capital Fund II, L.P.) - Conversion
Class A Common Stock
2021-03-19+2,732,440→ 5,662,814 total - Conversion
Series C Preferred Stock
2021-03-19−11,710.45→ 0 total(indirect: By SkyKnight Capital Fund II, L.P.)→ Class A Common Stock (1,171,045 underlying)
Footnotes (3)
- [F1]On March 19, 2021, the shares of Series C Preferred Stock held directly by SkyKnight Aero Holdings, LLC ("SkyKnight Aero Holdings") and SkyKnight Capital Fund II, L.P. "("SkyKnight Fund II") converted on a 100-for-one basis into the number of shares of Class A Common Stock shown in Column 7. The Series C Preferred Stock had no expiration date.
- [F2]Shares held by SkyKnight Aero Holdings. SkyKnight Capital, L.P. ("SkyKnight Capital") is the manager of SkyKnight Aero Holdings. SkyKnight Capital Management, LLC ("SkyKnight Capital Management") is the general partner of SkyKnight Capital. Matthew Ebbel is the managing member of SkyKnight Capital Management. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
- [F3]Shares held by SkyKnight Fund II. SkyKnight Capital II GP, LLC ("SkyKnight II GP") is the general partner of SkyKnight Fund II. Matthew Ebbel is the managing member of SkyKnight II GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.